Literature DB >> 21619863

Free radical scavengers and spin traps--therapeutic implications for ischemic stroke.

Thorsten R Doeppner1, Dirk M Hermann.   

Abstract

Ischemic stroke comprises a complex cascade of pathophysiological mediators among which reactive oxygen species (ROS) play a pivotal role. Although oxidative stress as one major component contributing to ischemia-reperfusion injury has been thoroughly studied before, efficient treatment options for patients with ischemic stroke have so far not been transferred into clinical practice. In this review, the authors first describe some of the fundamental pathophysiological mechanisms that are involved in ROS generation after cerebral ischemia. Thereafter, antioxidant defense mechanisms and pharmacological manipulation of oxidative stress in various models of experimental cerebral ischemia are reviewed. The authors finally comment on recent clinical studies analyzing the effect of an antioxidative therapy after ischemic stroke and present a short outlook for further studies on ROS-mediated injury after stroke.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21619863     DOI: 10.1016/j.bpa.2010.10.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  3 in total

1.  The Neuroprotection of Lysosomotropic Agents in Experimental Subarachnoid Hemorrhage Probably Involving the Apoptosis Pathway Triggering by Cathepsins via Chelating Intralysosomal Iron.

Authors:  Yang Wang; Anju Gao; Xiang Xu; Baoqi Dang; Wanchun You; Haiying Li; Zhengquan Yu; Gang Chen
Journal:  Mol Neurobiol       Date:  2014-08-12       Impact factor: 5.590

2.  Phase I clinical study of edaravone in healthy Chinese volunteers: safety and pharmacokinetics of single or multiple intravenous infusions.

Authors:  Hao Li; Kun Xu; Yongqing Wang; Hongwen Zhang; Tianping Li; Ling Meng; Xiaojian Gong; Haibo Zhang; Ning Ou; Jinman Ruan
Journal:  Drugs R D       Date:  2012-06-01

3.  NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives.

Authors:  Sarah K McCann; Carli L Roulston
Journal:  Brain Sci       Date:  2013-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.